1,618 results on '"Klein, Reinhild"'
Search Results
2. Patients with systemic sclerosis and low CD4 numbers after autologous stem cell transplantation have a favorable outcome
3. Autoantibodies targeting G protein-coupled receptors: An evolving history in autoimmunity. Report of the 4th international symposium
4. Increased soluble HLA in COVID-19 present a disease-related, diverse immunopeptidome associated with T cell immunity
5. The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinoma
6. A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity
7. Antiphospholipid Antibody Testing in a Maximum Care Hospital: Method-Dependent Differences.
8. SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition
9. Autoantibodies to beta tubulin in autoimmune liver diseases—Relation to pANCA and clinical relevance.
10. Autoantibodies to beta tubulin in autoimmune liver diseases - relation to pANCA and clinical relevance
11. The HLA ligandome landscape of chronic myeloid leukemia delineates novel T-cell epitopes for immunotherapy
12. Detection of IgE-autoantibodies to nuclear antigens in patients with systemic sclerosis and analysis of their clinical relevance
13. CD19-Targeting CAR T Cells for Myositis and Interstitial Lung Disease Associated With Antisynthetase Syndrome
14. The good and the bad of T cell cross-reactivity: challenges and opportunities for novel therapeutics in autoimmunity and cancer
15. Figures S1-S5 and Tables S1-S3 from Preexisting and Post–COVID-19 Immune Responses to SARS-CoV-2 in Patients with Cancer
16. Data from Preexisting and Post–COVID-19 Immune Responses to SARS-CoV-2 in Patients with Cancer
17. COVID-19 infection after autologous stem cell transplantation for systemic sclerosis
18. Immunology of Uveitis
19. Comparison of cytomegalovirus (CMV)-specific neutralization capacity of hyperimmunoglobulin (HIG) versus standard intravenous immunoglobulin (IVIG) preparations: Impact of CMV IgG normalization
20. Inhibition of effector B cells by ibrutinib in systemic sclerosis
21. A new synthetic toll-like receptor 1/2 ligand is an efficient adjuvant for peptide vaccination in a human volunteer
22. Invariant natural killer T cells are functionally impaired in patients with systemic sclerosis
23. Immunologic Findings in Workers Formerly Exposed to 2,3,7,8-Tetrachlorodibenzo-p-Dioxin and Its Congeners
24. timsTOF mass spectrometry-based immunopeptidomics refines tumor antigen identification
25. Functional autoantibodies in systemic sclerosis: influence of autologous stem cell transplantation and correlation with clinical outcome.
26. Functional autoantibodies in systemic sclerosis: influence of autologous stem cell transplantation and correlation with clinical outcome
27. Dynamics of Melanoma-Associated Epitope-Specific CD8+ T Cells in the Blood Correlate With Clinical Outcome Under PD-1 Blockade
28. Abstract 2008: The oncogenic fusion protein DNAJB1-PRKACA can be actively targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinoma
29. Sulphite oxidase (SO) – a mitochondrial autoantigen as target for humoral and cellular immune reactions in primary sclerosing cholangitis
30. Recurrent SARS-CoV-2 Infection and Impaired Immunologic Response in a Pediatric Oncologic Patient While Treated With Radiochemotherapy
31. iNKT cells can effectively inhibit IL-6 production by B cells in systemic sclerosis
32. Mit chronischem Müdigkeits- bzw. Fibromyalgie- syndrom assoziierte Manifestationen: Ausdruck einer Dysbalance im neuroendokrinoimmunologischen Regelkreis?
33. Analysis of anti–topoisomerase I antibodies in patients with systemic sclerosis before and after autologous stem cell transplantation
34. Functionally Active Antibodies to the Angiotensin II Type 1-Receptor Measured by a Luminometric Bioassay Do Not Correlate With Clinical Manifestations in Systemic Sclerosis: A Comparison With Antibodies to Vascular Receptors and Topoisomerase I Detected by ELISA
35. Is there any Relationship Between Eosinophilia Myalgia Syndrome (Ems) and Fibromyalgia Syndrome (Fms)? an Analysis Of Clinical and Immunological Data
36. Evaluation of Inhibitory Antibodies against the Muscarinic Acetylcholine Receptor Type 3 in Patients with Primary Biliary Cholangitis and Primary Sclerosing Cholangitis
37. Molekularbiologische Methoden zur HLA-Typisierung
38. Identification of α-tubulin as an autoantigen recognized by sera from patients with neuropsychiatric systemic lupus erythematosus
39. A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity
40. Designing a SARS-CoV-2 T-Cell-Inducing Vaccine for High-Risk Patient Groups
41. Phase I Trial of a Multi-Peptide COVID-19 Vaccine for the Induction of SARS-CoV-2 T-Cell Immunity
42. Autoantibodies to asialoglycoprotein receptor (ASGPR) measured by a novel ELISA—Revival of a disease-activity marker in autoimmune hepatitis
43. Preexisting and Post–COVID-19 Immune Responses to SARS-CoV-2 in Patients with Cancer
44. Increased Concentrations of Circulating Soluble MHC Class I-Related Chain A (sMICA) and sMICB and Modulation of Plasma Membrane MICA Expression: Potential Mechanisms and Correlation With Natural Killer Cell Activity in Systemic Lupus Erythematosus
45. Expression levels of HLA-DR in acute myeloid leukemia: implications for antigenicity and clinical outcome
46. Identification of immunodominant epitopes of alpha-crystallins recognized by antibodies in sera of patients with uveitis
47. Einfluss einer autologen Stammzelltransplantation auf funktionelle Autoantikörper gegen den Angiotensin Typ 1 Rezeptor bei Patienten mit progressiver systemischer Sklerodermie
48. Defibrotide for the treatment of PIMS-TS in two pediatric patients
49. Pharmacokinetics of natural mistletoe lectins after subcutaneous injection
50. Evidence for immunological (allergic) mechanisms in a subgroup of patients with phenprocoumon-induced liver disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.